alternatives to glp-1 agonists Costs Explained: Managing Coverage Challenges What Are Alternatives to GLP-1
Description
doi: 10.1002/cne.902280204 184 GebhardBHolstJJBiegelmayerCMiholicJ

Kidney Dis

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Most of the following reports caught my eye on Medscape.com, which has done a good job tracking developments with this class of drugs

Well-tolerated medicines with minimal side effects are necessary for the long-term management of chronic illnesses such as T2D [190]
